Core Laboratories (CLB) Total Current Liabilities (2022 - 2026)

Core Laboratories has reported Total Current Liabilities for 5 years, with the latest figure at $104.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 0.97% year-over-year to $104.7 million; the trailing twelve-month figure through Mar 2026 stood at $104.7 million (up 0.97% YoY), and the FY2025 full-year result was $106.0 million, up 3.48% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $104.7 million, down from $106.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $106.0 million in Q4 2025, with the low at $84.2 million in Q3 2023.
• Historically, Total Current Liabilities has averaged $97.5 million across 5 years, with a median of $97.6 million in 2024.
• Annual changes were most pronounced in 2023 — Total Current Liabilities slipped 14.58% — and 2025, when it increased 21.36%.
• Core Laboratories' Total Current Liabilities stood at $103.1 million in 2022, then decreased by 14.58% to $88.1 million in 2023, then climbed by 16.29% to $102.4 million in 2024, then rose by 3.48% to $106.0 million in 2025, then declined by 1.21% to $104.7 million in 2026.
• The last three Total Current Liabilities figures came in at $104.7 million (Q1 2026), $106.0 million (Q4 2025), and $95.7 million (Q3 2025), per Business Quant data.